Global Coronavirus Vaccine Market, By Infection Type (HCoV-229E, HCoV-OC43, SARS-CoV, HKU1-CoV, MERS-CoV, and Others (New Haven CoV)), By Vaccine Type (Inactivated Coronavirus Vaccine, Live Attenuated Coronavirus Vaccine, and S-Protein Based Coronavirus Vaccine), By End User (Hospitals, Clinics, Research Institutes, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI394320 | Publish Date: April 2023 | No. of Pages: 200

Global Coronavirus Vaccine Market By Overview

Coronaviruses are a group of viruses which cause diseases or infections in mammals as well as birds. Coronaviruses belong to the Torovirinae or Coronaviridae subfamily. Symptoms caused by these viruses include common cold to serious infections, pneumonia, severe respiratory complications, even kidney failure, and death. These symptoms are common among individuals with a weak immune system, individuals with cardiopulmonary disease, infants, and elderly people. Currently, there are no vaccines or drugs approved for treating diseased individuals. Yet, there are various drugs and vaccines in the pipeline which are still to be approved or launched. Science is fast but the Virus is moving at a faster speed.

Drivers and Restraints:

In the past few years, there has been an exponential rise in the demand for drugs and other related products as countries around the globe prepare for a potential outbreak. This is a major factor driving the global coronavirus vaccine market growth. Major pharmaceutical companies and research institutes such as the National Institutes of Health (NIH), U.S, are being aided by governments to develop novel vaccines and drugs to treat this deadly virus. The key players which are presently involved in the development of novel drugs for treating coronavirus include AbbVie Inc., BioCryst Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc., and companies discovering the development of vaccines as a preventive measure include Novavax, Inc., and Inovio Pharmaceuticals, Inc. Moreover, technological advancements in the pharmaceutical sector are projected to support the growth of the target market to a significant extent. For example, the development of nucleic acid vaccines that are DNA- and RNA-based which permit the human body to produce vaccine antigen. Such initiatives and events are anticipated to boost the target market growth over the forecast period. However, high cost involved in research and development of therapeutic vaccines and drugs, and time needed for each phase of clinical trials are among some of the major factors that may hamper the target market growth shortly.

Segmentation:

The global coronavirus vaccine market is segmented based on infection type, vaccine type, end-user, and region.

Based on infection type, the global coronavirus vaccine market is segmented into HCoV-229E, HCoV-OC43, SARS-CoV, HKU1-CoV, MERS-CoV, and Others (New Haven CoV).  Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV) are a new strain recently identified in humans. According to data published by WHO in 2019, there were about 2494 laboratory-confirmed cases of Middle East respiratory syndrome (MERS), including 858 associated deaths (case–fatality rate: 34.4%) stated worldwide. The majority of these cases were stated in Saudi Arabia. Based on the vaccine type, the global market is classified into inactivated coronavirus vaccine, live attenuated coronavirus vaccine and s-protein based coronavirus vaccine. Based on end-user, the target market is segmented into hospitals, clinics, research institutes, and others.

On the region, the global coronavirus vaccine market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The global market in North America is projected to estimate for highest revenue share, followed by the Europe market. Europe accounts for second-highest revenue share, owing to different coronavirus outbreaks in the recent past and presence of major players in countries in the region. Also, growing investments in R&D activities, along with strong support from the government is driving the growth of the target market in this region. Asia Pacific market is expected to grow at a significantly highest CAGR due to the ongoing outbreak 2020 in Wuhan. Moreover, increasing demand and need for novel vaccines and therapeutics for use as preventive measures is another factor anticipated to boost the growth of the target market.

Key Players:   

The key players operating the global coronavirus vaccine market includes Inovio Pharmaceuticals, Novavax Inc., Moderna Inc., Johnson & Johnson, NanoViricides, Inc., GGeneCure, LLC, Synairgen PLC, and AlphaVax, Inc. Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the Infection Types to gain a competitive edge in the target market. For instance, in January 2020, Inovio declared that it has been collaborating with Beijing Advaccine to advance INO-4800 vaccine against new coronavirus in China.

Detailed Segmentation:

Global Coronavirus Vaccine Market, By Infection Type:

  • HCoV-229E
  • HCoV-OC43
  • SARS-CoV
  • HKU1-CoV
  • MERS-CoV
  • Others (New Haven CoV)

Global Coronavirus Vaccine Market, By Vaccine Type:

  • Inactivated Coronavirus Vaccine
  • Live Attenuated Coronavirus Vaccine
  • S-Protein Based Coronavirus Vaccine

Global Coronavirus Vaccine Market, By End-user:

  • Hospitals
  • Clinics
  • Research Institutes
  • Others

Global Coronavirus Vaccine Market, By Region:

      • North America
        • North America Coronavirus Vaccine Market, By Infection Type
        • North America Coronavirus Vaccine Market, By Vaccine Type
        • North America Coronavirus Vaccine Market, By End-user
        • North America Coronavirus Vaccine Market, By Country
          • U.S.
          • Canada
      • Europe
        • Europe Coronavirus Vaccine Market, By Infection Type
        • Europe Coronavirus Vaccine Market, By Vaccine Type
        • Europe Coronavirus Vaccine Market, By End-user
        • Europe Coronavirus Vaccine Market, By Country
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
        • Asia Pacific Coronavirus Vaccine Market, By Infection Type
        • Asia Pacific Coronavirus Vaccine Market, By Vaccine Type
        • Asia Pacific Coronavirus Vaccine Market, By End-user
        • Asia Pacific Coronavirus Vaccine Market, By Country
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific  
      • Latin America
        • Latin America Coronavirus Vaccine Market, By Infection Type
        • Latin America Coronavirus Vaccine Market, By Vaccine Type
        • Latin America Coronavirus Vaccine Market, By End-user
        • Latin America Coronavirus Vaccine Market, By Country
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
        • Middle East & Africa Coronavirus Vaccine Market, By Infection Type
        • Middle East & Africa Coronavirus Vaccine Market, By Vaccine Type
        • Middle East & Africa Coronavirus Vaccine Market, By End-user
        • Middle East & Africa Coronavirus Vaccine Market, By Country
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Company Profile:

    •  
    • Inovio Pharmaceuticals
      • Company Overview 
        •  
        • Infection Type Portfolio
        • Key Highlights
        • Financial Performance
        • Business Strategies
    • Novavax Inc.
    • Johnson & Johnson
    • Moderna Inc.
    • NanoViricides, Inc.
    • GGeneCure, LLC
    • Synairgen PLC
    • AlphaVax, Inc.

 “*” marked represents similar segmentation in other categories in the respective section

Key Issues Addressed

  • What is the total revenue potential of the global coronavirus vaccine market? How that market is expected to grow during the study period?
  • What are the major growth opportunities in the coronavirus vaccine market?
  • Which companies are the major players in the global coronavirus vaccine market?

Global Coronavirus Vaccine Market By Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Coronavirus Vaccine Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Infection Type
      • Market Snippet, By Vaccine Type
      • Market Snippet, By End-user
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Coronavirus Vaccine Market, By Infection Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • HCoV-229E
      • Overview
      • Market Coronavirus Vaccine and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • HCoV-OC43
      • Overview
      • Market Coronavirus Vaccine and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • SARS-CoV
      • Overview
      • Market Coronavirus Vaccine and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • HKU1-CoV
      • Overview
      • Market Coronavirus Vaccine and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • MERS-CoV
      • Overview
      • Market Coronavirus Vaccine and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others (New Haven CoV)
      • Overview
      • Market Coronavirus Vaccine and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Coronavirus Vaccine Market, By Vaccine Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Inactivated Coronavirus Vaccine
      • Overview
      • Market Coronavirus Vaccine and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Live Attenuated Coronavirus Vaccine
      • Overview
      • Market Coronavirus Vaccine and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • S-Protein Based Coronavirus Vaccine
      • Overview
      • Market Coronavirus Vaccine and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Coronavirus Vaccine Market, By End-user, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Hospitals
      • Overview
      • Market Coronavirus Vaccine and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Clinics
      • Overview
      • Market Coronavirus Vaccine and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Research Institutes
      • Overview
      • Market Coronavirus Vaccine and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Coronavirus Vaccine and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Coronavirus Vaccine Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Coronavirus Vaccine and Forecast (US$ Mn), By Infection Type, 2020 – 2030
      • Market Coronavirus Vaccine and Forecast (US$ Mn), By Vaccine Type, 2020 – 2030
      • Market Coronavirus Vaccine and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Coronavirus Vaccine and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Coronavirus Vaccine and Forecast (US$ Mn), By Infection Type, 2020 – 2030
      • Market Coronavirus Vaccine and Forecast (US$ Mn), By Vaccine Type, 2020 – 2030
      • Market Coronavirus Vaccine and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Coronavirus Vaccine and Forecast (US$ Mn), By Country, 2020 – 2030
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Coronavirus Vaccine and Forecast (US$ Mn), By Infection Type, 2020 – 2030
      • Market Coronavirus Vaccine and Forecast (US$ Mn), By Vaccine Type, 2020 – 2030
      • Market Coronavirus Vaccine and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Coronavirus Vaccine and Forecast (US$ Mn), By Country, 2020 – 2030
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Coronavirus Vaccine and Forecast (US$ Mn), By Infection Type, 2020 – 2030
      • Market Coronavirus Vaccine and Forecast (US$ Mn), By Vaccine Type, 2020 – 2030
      • Market Coronavirus Vaccine and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Coronavirus Vaccine and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Coronavirus Vaccine and Forecast (US$ Mn), By Infection Type, 2020 – 2030
      • Market Coronavirus Vaccine and Forecast (US$ Mn), By Vaccine Type, 2020 – 2030
      • Market Coronavirus Vaccine and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Coronavirus Vaccine and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  10. Company Profiles
      • Inovio Pharmaceuticals
        • Company Overview
        • Infection Type Portfolio
        • Key Highlights
        • Financial Overview
        • Business Strategies
      • Novavax Inc.
      • Moderna Inc.
      • Johnson & Johnson
      • NanoViricides, Inc.
      • GGeneCure, LLC
      • Synairgen PLC
      • AlphaVax, Inc.
  11. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The coronavirus vaccine market is segmented based on infection type, vaccine type, end-user, and region.

the development of booster shots, the focus on addressing emerging variants, and advancements in mRNA vaccine technology, presenting significant opportunities in the global Coronavirus Vaccine Market.

the global effort to achieve herd immunity, the ongoing vaccination campaigns, advancements in vaccine technology, and the need for continuous vaccine development to address evolving virus variants.

The dominance in the Coronavirus Vaccine Market may vary based on vaccination campaigns, production capacities, and distribution networks. As of my last knowledge update in January 2022, North America, Europe, and Asia-Pacific were key regions, but the situation is dynamic.

The key players operating the global coronavirus vaccine market includes Inovio Pharmaceuticals, Novavax Inc., Moderna Inc., Johnson & Johnson, NanoViricides, Inc., GGeneCure, LLC, Synairgen PLC, and AlphaVax, Inc.